The construction of a brand new large steroid building and a new warehouse on the Farmabios premises in Gropello Cairoli (Italy) is moving forward nearly in plan. After construction work began in Dec 2019 , we can now observe clear progress in construction in July 2020. Here you can see some impressions of the construction
Bridgepoint, an international asset management firm with over €20 billion of assets, announced the acquisition of the PharmaZell Group in February 2020. After obtaining all necessary authorizations, we are very pleased to inform you that the acquisition of the PharmaZell Group by Bridgepoint was successfully completed on May 13th 2020. For further information please go
Farmabios is pleased to announce that it has just finalized the production and distribution of sanitizing gels to Covid-19 task forces and structures which are serving the neighboring area, as well as its employees and work force colleagues of PharmaZell in Germany. A little thought and supportive help to those who contributes to carry out
PharmaZell Group is very conscious of our important role and duty in delivering APIs to our customers and being an active part in maintaining the health system running. Up to now, the PharmaZell Group has been able to limit the impact of the Corona Virus outbreak (COVID-19) to the largest extent. Despite the fact that
During this critical and challenging period, Farmabios SpA states that our activities are regularly proceeding. We are conscious of the role and duty in delivering APIs, and our active part in the health system. We are doing our utmost to preserve our partners’ service continuously through our the work of our head quarter and manufacturing
As part of an ongoing investment program to enhance PharmaZell Group’s production output, we have initiated the construction of a brand new large steroid building and a new warehouse on the Farmabios premises in Gropello Cairoli (Italy). Construction work began in Dec 2019, a symbolic ground breaking ceremony is planned for Mar 2020. The investment
We are very glad to announce that the competent Italian authority (AIFA) has issued a renewed GMP certificate for our Farmabios SpA production facility [http://eudragmdp.ema.europa.eu/inspections/gmpc/generateGMPCPDF.do].
Global API supplier Farmabios announced today the addition of an ultra-pure synthetic Cannabidiol (CBD) drug substance to its portfolio. With an EU Drug Master File and cGMP manufacturing capacities, Farmabios is now positioned to fulfill a secure and scalable supply of CBD, from clinical needs to full-scale commercial operations. “As a long-standing supplier of specialized